A carregar...
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein highly expressed by prostate cancer cells. PSMA-based radioligand therapy (RLT) emerged as a promising therapeutic option for prostate cancer in the early 2000s, and has been clinically validated with great enthusiasm during t...
Na minha lista:
| Publicado no: | Ann Nucl Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680309/ https://ncbi.nlm.nih.gov/pubmed/33175360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12149-020-01549-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|